Komori
Premier Anti-Aging (4934) · InitiativeReframed

Expansion of Overseas Sales Markets, Primarily in Asia

First written in FY2020. 8 of 17 entries say "Reframed", first in FY2022-Q1. Latest entry: FY2026.

17entries
7years
8from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseReframedFY2022-Q1 – FY20232020: 12021: 420212022: 120222023: 120232024: 020242025: 120252026: 92026
Same theme, other companies
Winning Non-Japanese Customers in Asia and Strengthening Customer SupportA theme 25 companies write about · 0 as a headwind · 28 as a tailwind

Premier Anti-Aging moved to the "Worse" side of this theme in 2022, 3 years after the typical company in this theme (2019).

The whole theme swung hardest in 2020: 5 of 24 companies on the "Worse" side.

0 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 25 companies compared. The sentences above are computed from all 25.
Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「In July 2026, in response to the deteriorating business environment in China, we decided to consolidate our sales structure in China into cross-border e-commerce, which offers greater efficiency and growth potential, and to dissolve and liquidate the local subsidiary.」

    For our China business, we changed our policy from a sales structure through the local subsidiary to one concentrated on cross-border e-commerce, and decided to dissolve and liquidate the local subsidiary.
  2. FY2025RestatedAnnual report

    「Overseas, the company will strengthen its collaboration with inbound tourism and continue its efforts in China while closely monitoring market trends.」

    The company is maintaining its previous policy of focusing its overseas market expansion on Greater China, while pursuing collaboration with inbound tourism and continuing its China business.
  3. FY2023ReframedAnnual report

    「For its overseas business, the company has narrowed its target markets, which had expanded to more than 10 countries through its previous exploration, to countries and regions in Greater China that are closely linked to domestic inbound demand. It is expanding through a combination of cross-border e-commerce and general trade, working with local partners to implement a strategy that builds brand awareness suited to each market.」

    The company has restructured its plan from exploring all of Asia to focusing on countries and regions in Greater China and combining cross-border e-commerce, general trade and local partners.
  4. FY2022SoftenedAnnual report

    「In China, we have sold the DUO brand through cross-border EC and established the local subsidiary ベイ安美(上海)化粧品有限公司 to develop the business. However, during the current consolidated fiscal year, we have been reviewing our overseas strategy due in part to the impact of China’s advertising regulations and lockdowns caused by the novel coronavirus infection.」

    In response to the impact of advertising regulations and lockdowns in China, the company reviewed its previous overseas strategy. It continues to sell in China, Taiwan, Hong Kong, South Korea and other markets.
  5. FY2022-Q1ReframedAnnual report

    「In the overseas business, regulations imposed by Chinese authorities on the use of talent acted as a brake on the planned marketing initiatives, and we are redrafting our promotional strategy.」

    In response to Chinese regulations on the use of talent, we changed our response from the planned marketing initiatives to redrafting the promotional strategy.
  6. FY2021AdvancedAnnual report

    「In the overseas business, we made our first entry into 618, China’s major online shopping festival, selling the sensitive-skin cosmetics brand CITRANA through its Tmall flagship store and the anti-aging skincare brand DUO through its Tmall Global flagship store. The planned quantity of the limited-edition CITRANA gift box sold out as soon as sales began, marking a strong start.」

    We made our first entry into China’s major online shopping festival and Tmall, and the limited-edition CITRANA product sold out as soon as sales began.
  7. FY2021-Q3AdvancedAnnual report

    「In the overseas business in China, we established the local subsidiary ベイ安美(上海)化粧品有限公司※2 in February 2021 to expand the business and build a highly profitable structure over the medium to long term. In March 2021, we opened the first cross-border EC flagship store on the short-form video platform 抖音 (Douyin) for a Japanese company and Japanese brand, and in April 2021, we entered into a strategic business alliance with Tencent, a major Chinese technology company. We will continue building the foundation for the full-scale rollout of promotions targeting mainland China planned from the fourth quarter.」

    Following the establishment of the local subsidiary in China, we opened the first cross-border EC flagship store on 抖音 (Douyin) for a Japanese company and Japanese brand and entered into a strategic business alliance with Tencent, while advancing preparations for promotions targeting mainland China in the fourth quarter.
  8. FY2021-Q2AdvancedAnnual report

    「As one challenge in launching our overseas business, we had been conducting test marketing and recruiting personnel mainly in Asia. We have now established the local subsidiary ベイ安美(上海)化粧品有限公司※1 in Shanghai, China, to expand the business in China and build a highly profitable structure over the medium to long term.」

    In addition to raising awareness and securing numerous sales channels through live commerce in China, we established a local subsidiary in Shanghai and laid the foundation for expanding the China business and building a highly profitable structure through our own D2C store.
  9. FY2020First statedAnnual report

    「As part of our business expansion strategy, we are expanding overseas, mainly in Asia.」

    We sell through distributors in China, Taiwan and Hong Kong, with Taiwan serving in particular as a foothold for overseas expansion.
Moved together

"Revenue growth and improved profitability" moved the same way as this thread, in the same document, in 11 of its 17 moves.

1187766★123456
  1. ★This thread
  2. 1Revenue growth and improved profitability11×
  3. 2Impairment losses on investments and receivables due to the Chinese sales subsidiary's failure to achieve its business plan8×
  4. 3Improving Profit Margins and Stabilizing Sales7×
  5. 4Acquiring New Customers and Strengthening CRM for Existing and Dormant Customers7×
  6. 5Expansion of Wholesale Channels for Drugstores and Variety Stores6×
  7. 6Dependence on Interest-Bearing Debt and Financing Constraints6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Premier Anti-Aging yet. It last moved in the General Meetings of Shareholders of 2026-10-02: "Reframed".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Expansion of Overseas Sales Markets, Primarily in Asia | Premier Anti-Aging Co.,Ltd. (4934) | Komori